MedPath

Mind Programme for Women With Breast Cancer (Nationwide Coverage)

Not Applicable
Recruiting
Conditions
Breast Cancer Female
Registration Number
NCT06212414
Lead Sponsor
University of Coimbra
Brief Summary

The purpose of this research project is to optimize the Mind programme for women with breast cancer, taking into consideration the results from its pilot study, and to testits efficacy and cost-effectiveness through a 3-arm randomized controlled trial

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
Female
Target Recruitment
153
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Change from baseline cancer-specific quality of life at post-treatment and 6-month follow-upBaseline, post-treatment (2 months after baseline) and 6-month follow-up

EORTC QLQ-C30

Secondary Outcome Measures
NameTimeMethod
Major life events - controlling variable6-month follow-up

Major Life Events Questionnaire

Change from baseline health-related quality of life at post-treatment and 6-month follow-upBaseline, post-treatment (2 months after baseline) and 6-month follow-up

EQ-5D-5L

Change from baseline depressive symptoms and anxiety severity at post-treatment and 6-month follow-upBaseline, post-treatment (2 months after baseline) and 6-month follow-up

Hospital Anxiety and Depression Scale

Change from baseline psychological flexibility at post-treatment and 6-month follow-upBaseline, post-treatment (2 months after baseline) and 6-month follow-up

Comprehensive Assessment of Acceptance and Commitment Therapy Processes

Change from baseline self-compassion and mindfulness at post-treatment and 6-month follow-upBaseline, post-treatment (2 months after baseline) and 6-month follow-up

Self-Compassion Scale

Sociodemographic and clinical variables - controlling variablesBaseline
Change from baseline consumption of resources and costs in breast cancer at post-treatment and 6-month follow-upBaseline, post-treatment (2 months after baseline) and 6-month follow-up

This questionnaire was developed by the research team and adapted from the UK Cancer Costs Questionnaire (UKCC) Version 2.0 to assess the consumption of resources and economic costs associated with breast cancer.

Trial Locations

Locations (1)

Center for Research in Neuropsychology and Cognitive and Behavioral Intervention, University of Coimbra

🇵🇹

Coimbra, Portugal

Center for Research in Neuropsychology and Cognitive and Behavioral Intervention, University of Coimbra
🇵🇹Coimbra, Portugal
Andreia Soares, PhD
Contact
projeto.mind.uc@gmail.com
Joana Simões, PhD
Contact
projeto.mind.uc@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.